Life Trump Budget’s ‘America First’ Drug Policy Proposals Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal. Editorial Staff Apr 7
Life Many cancer patients don’t get genomic tests to guide treatment, study finds Strategic angle: Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival. Editorial Staff Apr 7
Life FDA Seeks to Strengthen Domestic Drug Manufacturing Through New Proposals In a move to enhance local drug production, the FDA has proposed new policies as part of the president's budget, aiming to support domestic drug development. Editorial Staff Apr 7
Life Health insurers score major win with higher 2027 Medicare Advantage rates The stocks of major Medicare Advantage insurers surged on the announcement. Editorial Staff Apr 7
Life Capping Insulin Costs at $35 May Improve Treatment Adherence for Type 2 Diabetes A recent study suggests that limiting insulin prices to $35 per month could enhance adherence to treatment among individuals with type 2 diabetes, highlighting the potential impact of cost on health outcomes. Editorial Staff Apr 7
Life Gilead Acquires Tubulis for Over $3 Billion to Boost Oncology Portfolio In a significant move to enhance its oncology pipeline, Gilead has announced the acquisition of Tubulis, a German biotech firm, for more than $3 billion. Editorial Staff Apr 7
Life Merck's HIV Prevention Pill: A Cost-Effective Solution Awaiting Generic Production With estimates suggesting Merck's experimental HIV prevention pill could cost under $5 annually, researchers are calling for the company to allow generic production. Editorial Staff Apr 7
Life Double Bonuses Increased MA Spending In Puerto Rico By $865 Million But Did Not Achieve Plan Improvement Goals Strategic angle: A study published in Health Affairs reveals the financial impact of double bonuses on Medicare Advantage spending in Puerto Rico. Editorial Staff Apr 7
Life Drug Prices, Behavioral Health, Hospitals, And More Strategic angle: Health Affairs discusses critical issues in healthcare. Editorial Staff Apr 7
Life First Year Of ACO Realizing Equity, Access, And Community Health Program Yields Good Quality, Savings Results Strategic angle: Health Affairs reports positive outcomes from the first year of the ACO program focused on equity and community health. Editorial Staff Apr 7
Life Lingering Effects Of The COVID-19 Pandemic On Non-COVID-19 Death Rates In The US, 2020–24 Strategic angle: A comprehensive study examining the impact of the COVID-19 pandemic on death rates from other causes in the United States. Editorial Staff Apr 7
Life ‘Most Favored Nation’ Drug Pricing Is An Idea Whose Time Has Come Strategic angle: Exploring the implications and potential benefits of implementing a Most Favored Nation drug pricing model. Editorial Staff Apr 7
Life Trends In Patient Cost Sharing For Hospital Care And Implications For Urban And Rural Hospital Revenue Strategic angle: An analysis of evolving patient cost-sharing practices and their impact on hospital finances. Editorial Staff Apr 7
Life Under Global Budgets, Hospital Utilization In Maryland Decreased By 11 Percentage Points More Than In Other States, 2013–23 Strategic angle: A study published in Health Affairs reveals significant reductions in hospital utilization in Maryland compared to other states. Editorial Staff Apr 7
Life US National Spending On Mental Health And Substance Use Disorder Treatment Driven By Case Growth, 2000–21 Strategic angle: Analysis of spending trends in mental health and substance use disorder treatment over two decades. Editorial Staff Apr 7
Life A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career Strategic angle: Brian Donovan had persuaded high school teachers and education researchers that prejudice might be ended by changing how genetics is taught. Editorial Staff Apr 7
Life FDA backs proposals to entice pharma companies to test, make drugs domestically Strategic angle: From tariffs to incentives, the administration wants to push companies to manufacture drugs in the U.S. Editorial Staff Apr 7
Life Opinion: How the insurance system quietly undoes recovery from addiction Strategic angle: People who have been stable for years are suddenly re-exposed to risk — not because their disease worsened, but because their coverage did. Editorial Staff Apr 7
Life Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI Strategic angle: “Health care will become autonomous because the survival of health systems depends upon it,” writes former Geisinger CEO Glenn Steele. Editorial Staff Apr 7
Life Research Revealing How the Brain Flushes Waste Named STAT Madness Editors’ Pick Strategic angle: For researcher Maiken Nedergaard, ‘diseases of aging are basically all about dirty brains’ Editorial Staff Apr 7